The following is a summary of “Anakinra improves retention rate of targeted treatments in Erdheim-Chester disease,” published ...

Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...

Drug major Pfizer Inc. (PFE) announced Monday positive topline results from the progression-free survival or PFS analysis of the ...

Aberrant activation of the Ras/Raf/MAPK/ERK kinase/extracellular signal-regulated kinase cascade and the VEGF pathway are commonly observed in breast cancer cells leading to malignant cell ...

The results indicated that biglycan and decorin activate the ERK and p38 MAPK signaling pathways, which are vital for bone remodeling and homeostasis. This study not only clarifies the distinct ...

The results indicated that biglycan and decorin activate the ERK and p38 MAPK signaling pathways, which are vital for bone remodeling and homeostasis. This study not only clarifies the distinct ...

lenta and TDCA, impaired colonic epithelium and increased activation of MAPK/ERK and proinflammatory pathways in recipient mice. Our findings indicate that cigarette smoking causes compositional ...

In this study, we investigated the expression changes and interactions between miR4298 and lncKRTAP5-6-3 in chronically UVB-damaged human keratinocyte cell line (HaCaT) cells and explored miR4298-MAPK ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...

Pfizer Inc. today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of BRAFTOVI® (encorafenib) in combination with cetuximab ...